A New Era of Veterinary Care: Dr. Linda Black on The Veterinary Roundtable

In this episode of The Veterinary Roundtable, Gallant CEO Dr. Linda Black shared how ready-to-use stem cell therapies are redefining veterinary medicine. Unlike traditional treatments that only manage symptoms, Gallant’s FDA-regulated therapies aim to restore health at the source—offering veterinarians a practical, accessible way to address chronic conditions.

From The Veterinary Roundtable
The Future of Stem Cell Therapy In Pets w/ Dr. Linda Black | The Veterinary Roundtable – EP138

Dr. Black highlighted Gallant’s lead program for refractory feline chronic gingivostomatitis, which has shown promising results in pivotal studies and is on track for conditional FDA approval in 2026. She also previewed Gallant’s broader pipeline, including therapies in development for osteoarthritis, chronic kidney disease, and atopic dermatitis in cats and dogs.

Gallant’s vision is clear: a future where every veterinary clinic has regenerative therapies on hand, giving pets not just more time—but more good years.